Clinical Trials
33 trialsSHERLOCK
University Health Network, Toronto
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
DP-04
AstraZeneca
ELEPHAS-02
Elephas
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
SCORE
Natera, Inc.
SPECIAL
University Health Network, Toronto
ELEPHAS-05
Elephas
LIBERATE
University Health Network, Toronto
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
DELFI-L101
Delfi Diagnostics Inc.
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREFER
Labcorp Corporation of America Holdings, Inc
MOM
Inova Health Care Services
EVIDENT
Sheffield Teaching Hospitals NHS Foundation Trust
MOHCCN-O
University Health Network, Toronto
ROOT
Taproot Health
OCTANE
University Health Network, Toronto
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
POSITive
European Institute of Oncology
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
G-DEFINER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Repertoire Immune Medicines
PIONEER
SpeciCare
EPR Tumor Oximetry With CE India Ink
Dartmouth-Hitchcock Medical Center
N1
CureOne
Assessing the Patient Experience in Cancer Care
Mayo Clinic
B-Receptor Signaling in Cardiomyopathy
Stanford University
TEST
M.D. Anderson Cancer Center
Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer
M.D. Anderson Cancer Center